322 related articles for article (PubMed ID: 24557415)
1. Chronic inflammation enhances NGF-β/TrkA system expression via EGFR/MEK/ERK pathway activation in Sjögren's syndrome.
Lisi S; Sisto M; Ribatti D; D'Amore M; De Lucro R; Frassanito MA; Lorusso L; Vacca A; Lofrumento DD
J Mol Med (Berl); 2014 May; 92(5):523-37. PubMed ID: 24557415
[TBL] [Abstract][Full Text] [Related]
2. Co-culture system of human salivary gland epithelial cells and immune cells from primary Sjögren's syndrome patients: an in vitro approach to study the effects of Rituximab on the activation of the Raf-1/ERK1/2 pathway.
Lisi S; Sisto M; D'Amore M; Lofrumento DD
Int Immunol; 2015 Apr; 27(4):183-94. PubMed ID: 25381666
[TBL] [Abstract][Full Text] [Related]
3. The metalloproteinase ADAM17 and the epidermal growth factor receptor (EGFR) signaling drive the inflammatory epithelial response in Sjögren's syndrome.
Sisto M; Lisi S; D'Amore M; Lofrumento DD
Clin Exp Med; 2015 May; 15(2):215-25. PubMed ID: 24664458
[TBL] [Abstract][Full Text] [Related]
4. TLR2 signals via NF-κB to drive IL-15 production in salivary gland epithelial cells derived from patients with primary Sjögren's syndrome.
Sisto M; Lorusso L; Lisi S
Clin Exp Med; 2017 Aug; 17(3):341-350. PubMed ID: 27260411
[TBL] [Abstract][Full Text] [Related]
5. Interleukin-15 as a potential new target in Sjögren's syndrome-associated inflammation.
Sisto M; Lorusso L; Lisi S
Pathology; 2016 Oct; 48(6):602-7. PubMed ID: 27567226
[TBL] [Abstract][Full Text] [Related]
6. Matriptase deletion initiates a Sjögren's syndrome-like disease in mice.
Yin H; Kosa P; Liu X; Swaim WD; Lai Z; Cabrera-Perez J; Di Pasquale G; Ambudkar IS; Bugge TH; Chiorini JA
PLoS One; 2014; 9(2):e82852. PubMed ID: 24551030
[TBL] [Abstract][Full Text] [Related]
7. Interleukin-36α axis is modulated in patients with primary Sjögren's syndrome.
Ciccia F; Accardo-Palumbo A; Alessandro R; Alessandri C; Priori R; Guggino G; Raimondo S; Carubbi F; Valesini G; Giacomelli R; Rizzo A; Triolo G
Clin Exp Immunol; 2015 Aug; 181(2):230-8. PubMed ID: 25902739
[TBL] [Abstract][Full Text] [Related]
8. Interleukin-17 and -22 synergy linking inflammation and EMT-dependent fibrosis in Sjögren's syndrome.
Sisto M; Lorusso L; Tamma R; Ingravallo G; Ribatti D; Lisi S
Clin Exp Immunol; 2019 Nov; 198(2):261-272. PubMed ID: 31165469
[TBL] [Abstract][Full Text] [Related]
9. Autoantigen-specific B cells and plasma cells are prominent in areas of fatty infiltration in salivary glands of patients with primary Sjögren's syndrome.
Skarstein K; Jensen JL; Galtung H; Jonsson R; Brokstad K; Aqrawi LA
Autoimmunity; 2019; 52(7-8):242-250. PubMed ID: 31661985
[TBL] [Abstract][Full Text] [Related]
10. CD40 on salivary gland epithelial cells: high constitutive expression by cultured cells from Sjögren's syndrome patients indicating their intrinsic activation.
Dimitriou ID; Kapsogeorgou EK; Moutsopoulos HM; Manoussakis MN
Clin Exp Immunol; 2002 Feb; 127(2):386-92. PubMed ID: 11876766
[TBL] [Abstract][Full Text] [Related]
11. Epigenetic dysregulation in salivary glands from patients with primary Sjögren's syndrome may be ascribed to infiltrating B cells.
Thabet Y; Le Dantec C; Ghedira I; Devauchelle V; Cornec D; Pers JO; Renaudineau Y
J Autoimmun; 2013 Mar; 41():175-81. PubMed ID: 23478041
[TBL] [Abstract][Full Text] [Related]
12. [Immunohistochemical study of inflammatory infiltrates in minor salivary glands in Sjögren's syndrome and other autoimmune diseases].
Tomás S; Coll J; Reth P; Corominas JM
Med Clin (Barc); 1998 Nov; 111(18):681-6. PubMed ID: 9887430
[TBL] [Abstract][Full Text] [Related]
13. Pro-inflammatory role of Anti-Ro/SSA autoantibodies through the activation of Furin-TACE-amphiregulin axis.
Lisi S; Sisto M; Lofrumento DD; Cucci L; Frassanito MA; Mitolo V; D'Amore M
J Autoimmun; 2010 Sep; 35(2):160-70. PubMed ID: 20673622
[TBL] [Abstract][Full Text] [Related]
14. CD4 T lymphocyte autophagy is upregulated in the salivary glands of primary Sjögren's syndrome patients and correlates with focus score and disease activity.
Alessandri C; Ciccia F; Priori R; Astorri E; Guggino G; Alessandro R; Rizzo A; Conti F; Minniti A; Barbati C; Vomero M; Pendolino M; Finucci A; Ortona E; Colasanti T; Pierdominici M; Malorni W; Triolo G; Valesini G
Arthritis Res Ther; 2017 Jul; 19(1):178. PubMed ID: 28743286
[TBL] [Abstract][Full Text] [Related]
15. Salivary gland epithelial cells from patients with Sjögren's syndrome induce B-lymphocyte survival and activation.
Rivière E; Pascaud J; Tchitchek N; Boudaoud S; Paoletti A; Ly B; Dupré A; Chen H; Thai A; Allaire N; Jagla B; Mingueneau M; Nocturne G; Mariette X
Ann Rheum Dis; 2020 Nov; 79(11):1468-1477. PubMed ID: 32843324
[TBL] [Abstract][Full Text] [Related]
16. Increased expression of interferon-λ in minor salivary glands of patients with primary Sjögren's syndrome and its synergic effect with interferon-α on salivary gland epithelial cells.
Ha YJ; Choi YS; Kang EH; Chung JH; Cha S; Song YW; Lee YJ
Clin Exp Rheumatol; 2018; 36 Suppl 112(3):31-40. PubMed ID: 28421993
[TBL] [Abstract][Full Text] [Related]
17. FcRL4
Haacke EA; Bootsma H; Spijkervet FKL; Visser A; Vissink A; Kluin PM; Kroese FGM
J Autoimmun; 2017 Jul; 81():90-98. PubMed ID: 28390747
[TBL] [Abstract][Full Text] [Related]
18. NKp30 Receptor Upregulation in Salivary Glands of Sjögren's Syndrome Characterizes Ectopic Lymphoid Structures and Is Restricted by Rituximab Treatment.
Pontarini E; Sciacca E; Grigoriadou S; Rivellese F; Lucchesi D; Fossati-Jimack L; Coleby R; Chowdhury F; Calcaterra F; Tappuni A; Lewis MJ; Fabris M; Quartuccio L; Bella SD; Bowman S; Pitzalis C; Mavilio D; De Vita S; Bombardieri M
Front Immunol; 2021; 12():706737. PubMed ID: 34594326
[TBL] [Abstract][Full Text] [Related]
19. Deficiency of β-arrestin2 alleviates apoptosis through GRP78-ATF6-CHOP signaling pathway in primary Sjögren's syndrome.
Huang L; Liu Q; Zhou T; Zhang J; Tian Q; Zhang Q; Wei W; Wu H
Int Immunopharmacol; 2021 Dec; 101(Pt A):108281. PubMed ID: 34710848
[TBL] [Abstract][Full Text] [Related]
20. Interleukin (IL)-22 receptor 1 is over-expressed in primary Sjogren's syndrome and Sjögren-associated non-Hodgkin lymphomas and is regulated by IL-18.
Ciccia F; Guggino G; Rizzo A; Bombardieri M; Raimondo S; Carubbi F; Cannizzaro A; Sireci G; Dieli F; Campisi G; Giacomelli R; Cipriani P; De Leo G; Alessandro R; Triolo G
Clin Exp Immunol; 2015 Aug; 181(2):219-29. PubMed ID: 25880879
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
